Change of glucometabolic activity per PSMA expression predicts survival in mCRPC patients non-responding to PSMA radioligand therapy: introducing a novel dual imaging biomarker.
- Resource Type
- Article
- Source
- Frontiers in Medicine; 2024, p1-10, 10p
- Subject
- Language
- ISSN
- 2296858X